{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T15:29:30Z","timestamp":1648826970124},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Infect Dis."],"published-print":{"date-parts":[[2015,9,1]]},"DOI":"10.1093\/infdis\/jiv062","type":"journal-article","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T00:34:13Z","timestamp":1423182853000},"page":"677-680","source":"Crossref","is-referenced-by-count":1,"title":["Adding \u201cFilaricide\u201d to the Gleevec Portfolio"],"prefix":"10.1093","volume":"212","author":[{"given":"Timothy G.","family":"Geary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles D.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,2,5]]},"reference":[{"key":"2016042507593050000_212.5.677.1","unstructured":"Uniting to Combat Neglected Tropical Diseases. The London Declaration. http:\/\/unitingtocombatntds.org\/downloads\/press\/ntd_event_london_declaration_on_ntds.pdf . Accessed 21 January 2015."},{"key":"2016042507593050000_212.5.677.2","unstructured":"World Health Organization. http:\/\/www.who.int\/neglected_diseases\/NTD_RoadMap_2012_Fullversion.pdf . Accessed 20 January 2015."},{"key":"2016042507593050000_212.5.677.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60586-7"},{"key":"2016042507593050000_212.5.677.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03586.x"},{"key":"2016042507593050000_212.5.677.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2011.10.003"},{"key":"2016042507593050000_212.5.677.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2012.04.005"},{"key":"2016042507593050000_212.5.677.7","doi-asserted-by":"publisher","DOI":"10.1186\/1756-3305-4-205"},{"key":"2016042507593050000_212.5.677.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002821"},{"key":"2016042507593050000_212.5.677.9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000497"},{"key":"2016042507593050000_212.5.677.10","doi-asserted-by":"publisher","DOI":"10.1186\/1756-3305-5-28"},{"key":"2016042507593050000_212.5.677.11","first-page":"409","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2013","volume":"89","author":"World Health Organization","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"2016042507593050000_212.5.677.12","unstructured":"World Health Organization. Progress report 2000\u20132009 and strategic plan 2010\u20132020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis. Geneva, Switzerland: World Health Organization, 2010."},{"key":"2016042507593050000_212.5.677.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-308X(10)73008-6"},{"key":"2016042507593050000_212.5.677.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2009.11.001"},{"key":"2016042507593050000_212.5.677.15","doi-asserted-by":"publisher","DOI":"10.1586\/eri.11.76"},{"key":"2016042507593050000_212.5.677.16","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328359f04a"},{"key":"2016042507593050000_212.5.677.17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/RRTM.S36642","article-title":"Chemotherapy in the treatment, control and elimination of human onchocerciasis","volume":"5","author":"Higazi","year":"2014","journal-title":"Res Rep Trop Med"},{"key":"2016042507593050000_212.5.677.18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu1152"},{"key":"2016042507593050000_212.5.677.19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/jiv065","article-title":"Targeting filarial Abl-like kinases: orally available, FDA-approved tyrosine kinase inhibitors are micro- and macrofilaricidal","volume":"212","author":"O'Connell","year":"2015","journal-title":"J Infect Dis"},{"key":"2016042507593050000_212.5.677.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2014.07.002"},{"key":"2016042507593050000_212.5.677.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2014.09.001"},{"key":"2016042507593050000_212.5.677.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003435"},{"key":"2016042507593050000_212.5.677.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2014.02.002"},{"key":"2016042507593050000_212.5.677.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003523"},{"key":"2016042507593050000_212.5.677.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2010.01.007"},{"key":"2016042507593050000_212.5.677.26","first-page":"3579","article-title":"Protein kinases as potential targets for novel anti-schistosomal strategies","volume":"18","author":"Beckmann","year":"2012","journal-title":"Curr Pharm Des"},{"key":"2016042507593050000_212.5.677.27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002923"},{"key":"2016042507593050000_212.5.677.28","doi-asserted-by":"publisher","DOI":"10.1038\/ng1396"},{"key":"2016042507593050000_212.5.677.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2014.07.005"},{"key":"2016042507593050000_212.5.677.30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003534"},{"key":"2016042507593050000_212.5.677.31","unstructured":"University of California. UCSF Global Health Sciences receives $6M for neglected diseases. http:\/\/www.universityofcalifornia.edu\/news\/ucsf-global-health-sciences-receives-6m-neglected-diseases . Accessed 18 January 2015."},{"key":"2016042507593050000_212.5.677.32","unstructured":"Johnson & Johnson. Johnson & Johnson joins public and private partners in the largest coordinated action to date to eliminate or control neglected tropical diseases. http:\/\/www.jnj.com\/news\/all\/johnson-and-johnson-joins-public-and-private-partners-in-the-largest-coordinated-action-to-date-to-eliminate-or-control-neglected-tropical-diseases . Accessed 22 January 2015."},{"key":"2016042507593050000_212.5.677.33","doi-asserted-by":"publisher","DOI":"10.1586\/eri.11.30"},{"key":"2016042507593050000_212.5.677.34","unstructured":"Drugs for Neglected Diseases initiative. Emodepside. http:\/\/www.dndi.org\/diseases-projects\/portfolio\/emodepside.html . Accessed 15 January 2015."},{"key":"2016042507593050000_212.5.677.35","unstructured":"Drugs for Neglected Diseases initiative. Bayer and DNDi sign first agreement to develop an innovative oral treatment for human river blindness. http:\/\/www.dndi.org\/media-centre\/press-releases\/2040-pr-bayer-filaria.html . Accessed 20 January 2015."}],"container-title":["Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/212\/5\/677\/5101484\/jiv062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T09:56:29Z","timestamp":1503482189000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jiv062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,5]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,8,6]]},"published-print":{"date-parts":[[2015,9,1]]}},"alternative-id":["10.1093\/infdis\/jiv062"],"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiv062","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,5]]}}}